Regulation of Vein Graft Hyperplasia by Survivin, an Inhibitor of Apoptosis Protein
OBJECTIVE—Survivin (SVV) is an inhibitor of apoptosis protein (IAP) that is upregulated in cancer and has recently been implicated in vascular injury. We sought to investigate the role of SVV in vein graft hyperplasia. METHODS AND RESULTS—Adenoviral constructs expressing a dominant-negative (AdT34A)...
Saved in:
Published in | Arteriosclerosis, thrombosis, and vascular biology Vol. 25; no. 10; pp. 2081 - 2087 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Philadelphia, PA
American Heart Association, Inc
01.10.2005
Hagerstown, MD Lippincott |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | OBJECTIVE—Survivin (SVV) is an inhibitor of apoptosis protein (IAP) that is upregulated in cancer and has recently been implicated in vascular injury. We sought to investigate the role of SVV in vein graft hyperplasia.
METHODS AND RESULTS—Adenoviral constructs expressing a dominant-negative (AdT34A) and wild-type (AdWT) SVV were used. Proliferation and apoptosis were assayed on endothelial cells (ECs) and smooth muscle cells (SMCs) from human saphenous vein. A rabbit carotid interposition vein graft model (N=31) was used, with adventitial gene transfer of SVV constructs. In vitro, overexpression of SVV was associated with protection from cytokine-induced apoptosis in ECs and SMCs; conversely, AdT34A directly induced apoptosis in these cells. SMC proliferation was increased by AdWT infection, whereas AdT34A reduced proliferation; both effects were serum-dependent. Expression of platelet-derived growth factor (PDGF) in SMCs was regulated by functional SVV expression in analogous fashion. In vivo, proliferation and apoptosis (7 days), as well as wall thickness (30 days), were modified by adenoviral-mediated SVV expression. Adventitial angiogenesis was regulated by the SVV-expressing constructs in a fashion parallel to wall thickness changes.
CONCLUSIONS—SVV is a critical regulator of multiple processes, including proliferation, apoptosis, and angiogenesis, that determine the remodeling response of vein grafts following arterialization. |
---|---|
AbstractList | OBJECTIVE: Survivin (SVV) is an inhibitor of apoptosis protein (IAP) that is upregulated in cancer and has recently been implicated in vascular injury. We sought to investigate the role of SVV in vein graft hyperplasia. METHODS AND RESULTS: Adenoviral constructs expressing a dominant-negative (AdT34A) and wild-type (AdWT) SVV were used. Proliferation and apoptosis were assayed on endothelial cells (ECs) and smooth muscle cells (SMCs) from human saphenous vein. A rabbit carotid interposition vein graft model (N=31) was used, with adventitial gene transfer of SVV constructs. In vitro, overexpression of SVV was associated with protection from cytokine-induced apoptosis in ECs and SMCs; conversely, AdT34A directly induced apoptosis in these cells. SMC proliferation was increased by AdWT infection, whereas AdT34A reduced proliferation; both effects were serum-dependent. Expression of platelet-derived growth factor (PDGF) in SMCs was regulated by functional SVV expression in analogous fashion. In vivo, proliferation and apoptosis (7 days), as well as wall thickness (30 days), were modified by adenoviral-mediated SVV expression. Adventitial angiogenesis was regulated by the SVV-expressing constructs in a fashion parallel to wall thickness changes. CONCLUSIONS: SVV is a critical regulator of multiple processes, including proliferation, apoptosis, and angiogenesis, that determine the remodeling response of vein grafts following arterialization. OBJECTIVESurvivin (SVV) is an inhibitor of apoptosis protein (IAP) that is upregulated in cancer and has recently been implicated in vascular injury. We sought to investigate the role of SVV in vein graft hyperplasia.METHODS AND RESULTSAdenoviral constructs expressing a dominant-negative (AdT34A) and wild-type (AdWT) SVV were used. Proliferation and apoptosis were assayed on endothelial cells (ECs) and smooth muscle cells (SMCs) from human saphenous vein. A rabbit carotid interposition vein graft model (N=31) was used, with adventitial gene transfer of SVV constructs. In vitro, overexpression of SVV was associated with protection from cytokine-induced apoptosis in ECs and SMCs; conversely, AdT34A directly induced apoptosis in these cells. SMC proliferation was increased by AdWT infection, whereas AdT34A reduced proliferation; both effects were serum-dependent. Expression of platelet-derived growth factor (PDGF) in SMCs was regulated by functional SVV expression in analogous fashion. In vivo, proliferation and apoptosis (7 days), as well as wall thickness (30 days), were modified by adenoviral-mediated SVV expression. Adventitial angiogenesis was regulated by the SVV-expressing constructs in a fashion parallel to wall thickness changes.CONCLUSIONSSVV is a critical regulator of multiple processes, including proliferation, apoptosis, and angiogenesis, that determine the remodeling response of vein grafts following arterialization. Survivin (SVV) is an inhibitor of apoptosis protein (IAP) that is upregulated in cancer and has recently been implicated in vascular injury. We sought to investigate the role of SVV in vein graft hyperplasia. Adenoviral constructs expressing a dominant-negative (AdT34A) and wild-type (AdWT) SVV were used. Proliferation and apoptosis were assayed on endothelial cells (ECs) and smooth muscle cells (SMCs) from human saphenous vein. A rabbit carotid interposition vein graft model (N=31) was used, with adventitial gene transfer of SVV constructs. In vitro, overexpression of SVV was associated with protection from cytokine-induced apoptosis in ECs and SMCs; conversely, AdT34A directly induced apoptosis in these cells. SMC proliferation was increased by AdWT infection, whereas AdT34A reduced proliferation; both effects were serum-dependent. Expression of platelet-derived growth factor (PDGF) in SMCs was regulated by functional SVV expression in analogous fashion. In vivo, proliferation and apoptosis (7 days), as well as wall thickness (30 days), were modified by adenoviral-mediated SVV expression. Adventitial angiogenesis was regulated by the SVV-expressing constructs in a fashion parallel to wall thickness changes. SVV is a critical regulator of multiple processes, including proliferation, apoptosis, and angiogenesis, that determine the remodeling response of vein grafts following arterialization. Objective— Survivin (SVV) is an inhibitor of apoptosis protein (IAP) that is upregulated in cancer and has recently been implicated in vascular injury. We sought to investigate the role of SVV in vein graft hyperplasia. Methods and Results— Adenoviral constructs expressing a dominant-negative (AdT34A) and wild-type (AdWT) SVV were used. Proliferation and apoptosis were assayed on endothelial cells (ECs) and smooth muscle cells (SMCs) from human saphenous vein. A rabbit carotid interposition vein graft model (N=31) was used, with adventitial gene transfer of SVV constructs. In vitro, overexpression of SVV was associated with protection from cytokine-induced apoptosis in ECs and SMCs; conversely, AdT34A directly induced apoptosis in these cells. SMC proliferation was increased by AdWT infection, whereas AdT34A reduced proliferation; both effects were serum-dependent. Expression of platelet-derived growth factor (PDGF) in SMCs was regulated by functional SVV expression in analogous fashion. In vivo, proliferation and apoptosis (7 days), as well as wall thickness (30 days), were modified by adenoviral-mediated SVV expression. Adventitial angiogenesis was regulated by the SVV-expressing constructs in a fashion parallel to wall thickness changes. Conclusions— SVV is a critical regulator of multiple processes, including proliferation, apoptosis, and angiogenesis, that determine the remodeling response of vein grafts following arterialization. Vein graft remodeling is incompletely understood. Survivin (SVV) is a unique inhibitor of apoptosis protein that has been implicated in cancer and vascular injury. We investigated the role of SVV in vein graft healing and demonstrate that SVV regulates several processes, including proliferation, apoptosis, and angiogenesis, that determine vein graft remodeling OBJECTIVE—Survivin (SVV) is an inhibitor of apoptosis protein (IAP) that is upregulated in cancer and has recently been implicated in vascular injury. We sought to investigate the role of SVV in vein graft hyperplasia. METHODS AND RESULTS—Adenoviral constructs expressing a dominant-negative (AdT34A) and wild-type (AdWT) SVV were used. Proliferation and apoptosis were assayed on endothelial cells (ECs) and smooth muscle cells (SMCs) from human saphenous vein. A rabbit carotid interposition vein graft model (N=31) was used, with adventitial gene transfer of SVV constructs. In vitro, overexpression of SVV was associated with protection from cytokine-induced apoptosis in ECs and SMCs; conversely, AdT34A directly induced apoptosis in these cells. SMC proliferation was increased by AdWT infection, whereas AdT34A reduced proliferation; both effects were serum-dependent. Expression of platelet-derived growth factor (PDGF) in SMCs was regulated by functional SVV expression in analogous fashion. In vivo, proliferation and apoptosis (7 days), as well as wall thickness (30 days), were modified by adenoviral-mediated SVV expression. Adventitial angiogenesis was regulated by the SVV-expressing constructs in a fashion parallel to wall thickness changes. CONCLUSIONS—SVV is a critical regulator of multiple processes, including proliferation, apoptosis, and angiogenesis, that determine the remodeling response of vein grafts following arterialization. |
Author | Wang, Grace J Sui, Xin Xin Simosa, Hector F Altieri, Dario C Conte, Michael S Jain, Mukesh K |
AuthorAffiliation | From Vascular Surgery Research Laboratory (G.J.W., X.X.S., H.F.S., M.S.C.), Brigham and Womenʼs Hospital and Harvard Medical School, Boston, Mass; Cardiovascular Division (M.K.J.), Brigham and Womenʼs Hospital, Boston, Mass; Department of Cancer Biology and the Cancer Center (D.C.A.), University of Massachusetts Medical School, Worcester, Mass |
AuthorAffiliation_xml | – name: From Vascular Surgery Research Laboratory (G.J.W., X.X.S., H.F.S., M.S.C.), Brigham and Womenʼs Hospital and Harvard Medical School, Boston, Mass; Cardiovascular Division (M.K.J.), Brigham and Womenʼs Hospital, Boston, Mass; Department of Cancer Biology and the Cancer Center (D.C.A.), University of Massachusetts Medical School, Worcester, Mass |
Author_xml | – sequence: 1 givenname: Grace surname: Wang middlename: J fullname: Wang, Grace J organization: From Vascular Surgery Research Laboratory (G.J.W., X.X.S., H.F.S., M.S.C.), Brigham and Womenʼs Hospital and Harvard Medical School, Boston, Mass; Cardiovascular Division (M.K.J.), Brigham and Womenʼs Hospital, Boston, Mass; Department of Cancer Biology and the Cancer Center (D.C.A.), University of Massachusetts Medical School, Worcester, Mass – sequence: 2 givenname: Xin surname: Sui middlename: Xin fullname: Sui, Xin Xin – sequence: 3 givenname: Hector surname: Simosa middlename: F fullname: Simosa, Hector F – sequence: 4 givenname: Mukesh surname: Jain middlename: K fullname: Jain, Mukesh K – sequence: 5 givenname: Dario surname: Altieri middlename: C fullname: Altieri, Dario C – sequence: 6 givenname: Michael surname: Conte middlename: S fullname: Conte, Michael S |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17173302$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/16123317$$D View this record in MEDLINE/PubMed |
BookMark | eNpdkM1q3DAUhUVJyF_zCsUE2lXt6seS5e6G0CaBQEuTZiuuNVJHqUdyJDth3j5yZmAg2lwtvnPv4TtFBz54g9AFwRUhgnzDpFrcP1Q4PyKZlLwSgnBWSfiATgindVkLJg7yHzdtyUVNj9FpSo-ZrynFR-g4b6GMkeYE3f0x_6YeRhd8EWzxYJwvriLYsbjeDCYOPSQHRbcp7qb47J6d_1qAL278ynVuDHHOLIYwjCG5VPyOYcwLPqJDC30y57t5hv7-_HF_eV3e_rq6uVzclppjQUrBGom1MZYbI4W2uCOSQ91aroWwSyDUAKcAxLZcyg5wI2i75Ixr3jXaaHaGvmz3DjE8TSaNau2SNn0P3oQpKSFFXVPWZPDiHfgYpuhzN0WzEtligjP0fQvpGFKKxqohujXEjSJYzd4VJip7V3vv6s27kpDDn3YXpm5tlvvoTnQGPu8ASBp6G8Frl_ZckxmGaebqLfcS-tHE9L-fXkxUKwP9uJpP10xgXlKMOZmLlHMZwl4B_Z-crA |
CODEN | ATVBFA |
CitedBy_id | crossref_primary_10_1093_eurjhf_hfp135 crossref_primary_10_1096_fj_12_225615 crossref_primary_10_1182_blood_2006_06_028068 crossref_primary_10_1517_14656566_8_7_901 crossref_primary_10_3109_13880209_2014_884605 crossref_primary_10_1007_s10237_010_0224_8 crossref_primary_10_2353_ajpath_2010_091082 crossref_primary_10_1002_jcp_22676 crossref_primary_10_1111_acel_12844 crossref_primary_10_1586_14779072_6_5_641 crossref_primary_10_1063_5_0157549 crossref_primary_10_1186_s12967_017_1270_0 crossref_primary_10_1016_j_ajpath_2012_06_023 crossref_primary_10_1016_j_jvssci_2023_100126 crossref_primary_10_1016_j_jvs_2007_02_031 crossref_primary_10_1517_13543781003727099 crossref_primary_10_1016_j_jvs_2016_01_030 crossref_primary_10_1152_ajpheart_00637_2010 crossref_primary_10_1038_sj_mt_6300381 crossref_primary_10_1080_03079457_2012_663077 crossref_primary_10_1016_j_jacc_2009_04_006 crossref_primary_10_36660_abc_20200761 crossref_primary_10_1080_14779072_2019_1563483 crossref_primary_10_1016_j_mam_2017_07_005 crossref_primary_10_1016_j_mehy_2006_11_055 crossref_primary_10_1097_00029330_200811020_00005 crossref_primary_10_2310_6670_2007_00049 crossref_primary_10_1016_j_vph_2012_07_008 crossref_primary_10_1371_journal_pone_0113480 crossref_primary_10_1016_j_jvs_2018_05_206 crossref_primary_10_1016_j_mvr_2019_103905 crossref_primary_10_1016_j_surg_2006_04_004 crossref_primary_10_1007_s10557_007_6018_2 crossref_primary_10_1152_ajpheart_00089_2011 crossref_primary_10_1371_journal_pone_0264217 crossref_primary_10_1517_13543784_16_6_803 crossref_primary_10_1113_expphysiol_2009_050971 crossref_primary_10_1152_ajpheart_00079_2008 crossref_primary_10_1016_j_jvs_2009_02_242 |
Cites_doi | 10.1161/circ.101.12.1362 10.1016/S0741-5214(96)70203-3 10.1016/0022-4804(91)90029-L 10.1161/atvb.16.1.19 10.1182/blood-2003-05-1756 10.1161/01.cir.0000145138.25577.f1 10.1172/JCI200422222 10.1161/01.res.0000097864.24725.60 10.1016/S0735-1097(97)00076-4 10.1073/pnas.89.22.10984 10.1038/nrc968 10.1038/sj.onc.1205353 10.1073/pnas.0406665101 10.1074/jbc.M309479200 10.1016/S1072-7515(00)00320-3 10.1016/S0002-9440(10)64131-4 10.1016/S0960-9822(00)00769-7 10.1161/01.atv.0000116865.98067.31 10.1093/emboj/17.8.2215 10.1074/jbc.M003670200 10.1016/j.bbrc.2004.08.149 10.1016/j.jvs.2005.01.006 10.1172/JCI200112983 10.1038/sj.onc.1207113 10.1038/nm750 10.1161/circ.95.12.2684 10.1074/jbc.M106643200 10.1161/circ.94.7.1655 10.1152/ajpheart.00760.2003 10.1177/1358836X0000500207 |
ContentType | Journal Article |
Copyright | 2005 American Heart Association, Inc. 2005 INIST-CNRS Copyright American Heart Association, Inc. Oct 2005 |
Copyright_xml | – notice: 2005 American Heart Association, Inc. – notice: 2005 INIST-CNRS – notice: Copyright American Heart Association, Inc. Oct 2005 |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION K9. 7X8 |
DOI | 10.1161/01.ATV.0000183885.66153.8a |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4636 |
EndPage | 2087 |
ExternalDocumentID | 909089931 10_1161_01_ATV_0000183885_66153_8a 16123317 17173302 00043605-200510000-00011 |
Genre | Research Support, U.S. Gov't, P.H.S Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NCI NIH HHS grantid: CA90917 – fundername: NHLBI NIH HHS grantid: HL072952 – fundername: NHLBI NIH HHS grantid: 5T32-HL07734 – fundername: NHLBI NIH HHS grantid: K08 HL04189-01 – fundername: NCI NIH HHS grantid: CA78810 – fundername: NHLBI NIH HHS grantid: HL54131 |
GroupedDBID | - .Z2 01R 08R 0R 1J1 23N 2WC 3O- 40H 4Q1 4Q2 4Q3 53G 55 5GY 5RE 5VS 71W 77Y 7O 7O~ AAAXR AAMOA AAMTA AAPBV AARTV AAXQO ABBUW ABXVJ ABZAD ACDDN ACEWG ACGFS ACGOD ACPRK ACWDW ACWRI ACXNZ ADACO ADBBV ADFPA ADNKB AE3 AENEX AFFNX AFUWQ AHMBA AHULI AHVBC AIJEX AJIOK AJNYG AJYGW ALMA_UNASSIGNED_HOLDINGS AMJPA ASCII AWKKM BAWUL BOYCO C1A C45 CS3 DIK DUNZO E.X E3Z EBS EJD EX3 F2K F2L F2M F2N F5P FL- FRP FW0 GJ GX1 H0 H0~ H13 HZ IKYAY IN IN~ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B LI0 N9A N~7 N~B N~M O0- O9- OAG OAH OB2 OCUKA ODA OHASI OK1 OL1 OLG OLH OLU OLV OLW OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWW OWY OXXIT P-K P2P PQEST PQQKQ PZZ RAH RHF RIG RLZ RSW S4R S4S V2I WOQ WOW X3V X3W X7M Z2 ZA5 ZGI --- .3C .55 .GJ 0R~ AAGIX AAHPQ AAQKA AASOK AAUGY ABASU ABDIG ABQRW ACCJW ACILI ADGGA AE6 AEETU AFDTB AGINI AHJKT AHOMT AHRYX AJNWD AKALU AKULP ALMTX AMKUR AMNEI AOHHW AYCSE BS7 DIWNM EEVPB FCALG GNXGY GQDEL HZ~ IKREB IPNFZ IQODW OJAPA OWU OWV OWX OWZ T8P TEORI TR2 TSPGW VVN W3M W8F XXN XYM YFH ZZMQN AAAAV AAIQE AASCR ABJNI ABVCZ ACXJB ADHPY AHQNM AINUH AJZMW CGR CUY CVF ECM EIF ERAAH HLJTE NPM AAYXX CITATION K9. 7X8 |
ID | FETCH-LOGICAL-c5061-63780ceef5ee86cf0b185a49f5c66fda12ea52aa1f9588ba07629d535c5b7cec3 |
ISSN | 1079-5642 |
IngestDate | Sat Aug 17 02:32:35 EDT 2024 Thu Aug 29 12:51:45 EDT 2024 Fri Aug 23 00:17:21 EDT 2024 Sat Sep 28 08:40:24 EDT 2024 Sun Oct 22 16:04:00 EDT 2023 Thu Aug 13 19:50:12 EDT 2020 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 10 |
Keywords | Vascular disease Angiogenesis survivin proliferation Hyperplasia Atherosclerosis Cardiovascular disease intimal hyperplasia Apoptosis |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c5061-63780ceef5ee86cf0b185a49f5c66fda12ea52aa1f9588ba07629d535c5b7cec3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ahajournals.org/doi/pdf/10.1161/01.ATV.0000183885.66153.8a |
PMID | 16123317 |
PQID | 204289010 |
PQPubID | 49288 |
PageCount | 7 |
ParticipantIDs | proquest_miscellaneous_68644237 proquest_journals_204289010 crossref_primary_10_1161_01_ATV_0000183885_66153_8a pubmed_primary_16123317 pascalfrancis_primary_17173302 wolterskluwer_health_00043605-200510000-00011 |
ProviderPackageCode | L-C C45 7O~ AARTV ADFPA OLH ASCII OLG AAMOA ODA ABZAD ABBUW JK3 ADNKB JK8 H0~ 1J1 OLV OLU JG8 OLW OLZ OLY F2K F2M F2L F2N OHASI AHVBC AJNYG FL- KMI K8S OVLEI AJIOK OPUJH V2I S4R S4S 4Q1 DUNZO OAG 4Q2 OVDNE 4Q3 AMJPA OAH OVD 71W AHULI OB2 ACEWG .Z2 N~7 IKYAY OVIDH AWKKM 40H N~B OUVQU ORVUJ X3V X3W ACDDN ACWRI BOYCO AIJEX AAXQO AAMTA AAAXR E.X OWW OCUKA OWY 01R ACXNZ OL1 ABXVJ IN~ KD2 OXXIT 77Y ACWDW JF9 FW0 |
PublicationCentury | 2000 |
PublicationDate | 2005-October |
PublicationDateYYYYMMDD | 2005-10-01 |
PublicationDate_xml | – month: 10 year: 2005 text: 2005-October |
PublicationDecade | 2000 |
PublicationPlace | Philadelphia, PA Hagerstown, MD |
PublicationPlace_xml | – name: Philadelphia, PA – name: Hagerstown, MD – name: United States – name: Hagerstown |
PublicationTitle | Arteriosclerosis, thrombosis, and vascular biology |
PublicationTitleAlternate | Arterioscler Thromb Vasc Biol |
PublicationYear | 2005 |
Publisher | American Heart Association, Inc Lippincott |
Publisher_xml | – name: American Heart Association, Inc – name: Lippincott |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_1_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_4_2 e_1_3_2_12_2 e_1_3_2_3_2 e_1_3_2_13_2 e_1_3_2_2_2 e_1_3_2_14_2 |
References_xml | – ident: e_1_3_2_26_2 doi: 10.1161/circ.101.12.1362 – ident: e_1_3_2_20_2 doi: 10.1016/S0741-5214(96)70203-3 – ident: e_1_3_2_8_2 doi: 10.1016/0022-4804(91)90029-L – ident: e_1_3_2_14_2 doi: 10.1161/atvb.16.1.19 – ident: e_1_3_2_28_2 doi: 10.1182/blood-2003-05-1756 – ident: e_1_3_2_30_2 doi: 10.1161/01.cir.0000145138.25577.f1 – ident: e_1_3_2_1_2 – ident: e_1_3_2_23_2 doi: 10.1172/JCI200422222 – ident: e_1_3_2_4_2 doi: 10.1161/01.res.0000097864.24725.60 – ident: e_1_3_2_10_2 doi: 10.1016/S0735-1097(97)00076-4 – ident: e_1_3_2_12_2 – ident: e_1_3_2_11_2 doi: 10.1073/pnas.89.22.10984 – ident: e_1_3_2_5_2 doi: 10.1038/nrc968 – ident: e_1_3_2_19_2 doi: 10.1038/sj.onc.1205353 – ident: e_1_3_2_24_2 doi: 10.1073/pnas.0406665101 – ident: e_1_3_2_18_2 doi: 10.1074/jbc.M309479200 – ident: e_1_3_2_31_2 doi: 10.1016/S1072-7515(00)00320-3 – ident: e_1_3_2_15_2 doi: 10.1016/S0002-9440(10)64131-4 – ident: e_1_3_2_16_2 doi: 10.1016/S0960-9822(00)00769-7 – ident: e_1_3_2_2_2 doi: 10.1161/01.atv.0000116865.98067.31 – ident: e_1_3_2_22_2 doi: 10.1093/emboj/17.8.2215 – ident: e_1_3_2_21_2 doi: 10.1074/jbc.M003670200 – ident: e_1_3_2_27_2 doi: 10.1016/j.bbrc.2004.08.149 – ident: e_1_3_2_7_2 doi: 10.1016/j.jvs.2005.01.006 – ident: e_1_3_2_9_2 doi: 10.1172/JCI200112983 – ident: e_1_3_2_32_2 doi: 10.1038/sj.onc.1207113 – ident: e_1_3_2_6_2 doi: 10.1038/nm750 – ident: e_1_3_2_3_2 doi: 10.1161/circ.95.12.2684 – ident: e_1_3_2_17_2 doi: 10.1074/jbc.M106643200 – ident: e_1_3_2_25_2 doi: 10.1161/circ.94.7.1655 – ident: e_1_3_2_13_2 doi: 10.1152/ajpheart.00760.2003 – ident: e_1_3_2_29_2 doi: 10.1177/1358836X0000500207 |
SSID | ssj0004220 |
Score | 2.0665624 |
Snippet | OBJECTIVE—Survivin (SVV) is an inhibitor of apoptosis protein (IAP) that is upregulated in cancer and has recently been implicated in vascular injury. We... Survivin (SVV) is an inhibitor of apoptosis protein (IAP) that is upregulated in cancer and has recently been implicated in vascular injury. We sought to... Objective— Survivin (SVV) is an inhibitor of apoptosis protein (IAP) that is upregulated in cancer and has recently been implicated in vascular injury. We... OBJECTIVE: Survivin (SVV) is an inhibitor of apoptosis protein (IAP) that is upregulated in cancer and has recently been implicated in vascular injury. We... OBJECTIVESurvivin (SVV) is an inhibitor of apoptosis protein (IAP) that is upregulated in cancer and has recently been implicated in vascular injury. We sought... |
SourceID | proquest crossref pubmed pascalfrancis wolterskluwer |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2081 |
SubjectTerms | Adenoviridae - genetics Animals Apoptosis - physiology Atherosclerosis (general aspects, experimental research) Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Carotid Arteries - pathology Carotid Arteries - surgery Carotid Artery Diseases - metabolism Carotid Artery Diseases - pathology Carotid Artery Diseases - physiopathology Cell Division - physiology Cells, Cultured Diseases of the peripheral vessels. Diseases of the vena cava. Miscellaneous Endothelium, Vascular - cytology Endothelium, Vascular - metabolism Genetic Vectors Graft Survival - physiology Humans Hyperplasia Inhibitor of Apoptosis Proteins Jugular Veins - pathology Jugular Veins - transplantation Medical sciences Microtubule-Associated Proteins - genetics Microtubule-Associated Proteins - metabolism Muscle, Smooth, Vascular - cytology Muscle, Smooth, Vascular - metabolism Neoplasm Proteins - genetics Neoplasm Proteins - metabolism Neovascularization, Pathologic - metabolism Neovascularization, Pathologic - pathology Neovascularization, Pathologic - physiopathology Platelet-Derived Growth Factor - metabolism Rabbits Saphenous Vein - cytology Signal Transduction - physiology Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases Surgery of the heart Survivin Vascular surgery: aorta, extremities, vena cava. Surgery of the lymphatic vessels |
Title | Regulation of Vein Graft Hyperplasia by Survivin, an Inhibitor of Apoptosis Protein |
URI | http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00043605-200510000-00011 https://www.ncbi.nlm.nih.gov/pubmed/16123317 https://www.proquest.com/docview/204289010/abstract/ https://search.proquest.com/docview/68644237 |
Volume | 25 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELaWIiEkhHgTCiUHbiVLXnacY4WAqqhI0C3aW2QnDrsqTaLNbhHc-d_M2M5joZWAS7SbOE6UbzyeGc98JuSFTFgaU8q8pEhyL2aSeqmfFp4vJE8xDSPJMQ55_IEdnsZHczqfTH6OspY2aznNf1xaV_I_qMI5wBWrZP8B2b5TOAG_AV84AsJw_CuMP5mN5K3Nd6GW1f6XlSjX-wvwLleNrpBE-7LdgEK4MGwBAlMbF0sJI1kvEIimbtY10pJoygZLxN3z0iKVc93Cc1fYBjvAjRXOZfcP4-59NqtldBqC9EaRvFsJ0B6j9SedQTCHt50ve9k8AaFphZkJcSFhSDk-EubNjzdnql3YuGwXqKB9yhvMM1a5hrGHBGVj7WvKnjsp88e61Debufyp5FmgCxemB7PPmn8S1BLndMrQeJ1yMb4JAGvONfwBEs1EplD0N4rt7tI1cj1MUoo-_PuPI9L5MOz4aqHlq6sfjAy0tqstM-dWAziIr6XZKuUyXwbafKsxPaI909URIxtndofcts6Je2Ak7S6ZqOoeuXFs0y_uk5NB4Ny6dFHgXC1w7kjgXPnd7QTupSsqtxc3vKcXN9eK2wNy-vbN7PWhZ3fl8HIKxp_HooT7YFqVVCnO8tKXYPKJOC1pzlhZiCBUgoZCBGVKOZfCh-k2LWhEcyqTXOXRQ7JT1ZV6TFwVyrKkSUAFL-JcljxRNKQCffpCRLxwSNR9xKwx5CuZdlpZkPlBBihkAwqZRiHjwiF7W997uBUzTiI_dMhuB0BmR3ObhRg8wFwlhzzvr4KqxfUzUal602aMg_MA6sshjwxqQ88WdYd4WzBmppg50wvuDIZEqCdBy-YQBE-u7GmX3BzG0FOys15t1DMwf9dyTwvnL-8Zqjw |
link.rule.ids | 315,786,790,27957,27958 |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Regulation+of+vein+graft+hyperplasia+by+survivin%2C+an+inhibitor+of+apoptosis+protein&rft.jtitle=Arteriosclerosis%2C+thrombosis%2C+and+vascular+biology&rft.au=Wang%2C+Grace+J&rft.au=Sui%2C+Xin+Xin&rft.au=Simosa%2C+Hector+F&rft.au=Jain%2C+Mukesh+K&rft.date=2005-10-01&rft.eissn=1524-4636&rft.volume=25&rft.issue=10&rft.spage=2081&rft_id=info:doi/10.1161%2F01.ATV.0000183885.66153.8a&rft_id=info%3Apmid%2F16123317&rft.externalDocID=16123317 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1079-5642&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1079-5642&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1079-5642&client=summon |